Market News & Trends
West Announces Plans to Expands Global Capabilities to Meet Demand
West Pharmaceutical Services, Inc. recently announced it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility…
Capsugel Expands Its Lipid Multi-Particulate Technology Offering
Capsugel recently announced the broad commercial availability of its proprietary lipid multi-particulate (LMP) technology. Capsugel’s LMP technology is an innovative drug delivery platform with multiple…
Exostar Receives $5-Million Investment From Merck GHI
Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, recently announced a $5-million investment to enable them to accelerate…
Progenics Receives $40-Million Milestone
Progenics Pharmaceuticals, Inc. recently announced it received a $40-million milestone payment from its worldwide collaboration partner, Salix Pharmaceuticals, Ltd. upon the US FDA’s recent approval…
Changes & Trends in Solubilization Outsourcing
By: Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc. Approved drugs over the last thirty-five years are evidence that there is a…
West Pharmaceutical Services & HealthPrize Technologies Join Forces
West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC recently announced a strategic collaboration to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient engagement platform with…
Catalent Expands Technology Offerings in Biologics, Acquires Redwood Bioscience
Catalent Pharma Solutions recently announced it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag Antibody-Drug Conjugate (ADC) technology platform. In Catalent’s…
Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization & Glycoprotein Biosynthesis
Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the USA under ICH Q7-compliant conditions. “Mannose has long been recognized…
SGS Life Science Services Announces New Facility
SGS Life Science Services recently announced further investment in the French market, with a new facility in Villeneuve la Garenne. The new location, which will…
Drug Delivery Institute to Collaborate With Lung Cancer Alliance
The Catalent Applied Drug Delivery Institute recently announced it is to collaborate with the Lung Cancer Alliance on patient research in early October. The collaboration…
Ultra-Rapid-Acting Insulin Formulations Will Revolutionize Type 1 Diabetes Treatment Market by 2019
LONDON, UK (GlobalData), 7 October 2014 - Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential to radically change the insulin…
US Manufactured API Tromethamine From FDA-Registered Facility Available Quarter4 2014
BioSpectra recently announced its cGMP, US-manufactured ICH Q7-based Tromethamine, intended for use as an Active Pharmaceutical Ingredient, will be produced in its new FDA-registered facility…
Unilife Signs 15-Year Commercial Supply Agreement for Wearable Injectors With Sanofi
York, PA. – October 6, 2014 - Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced…
Global Market for Nanoparticles Instrumentation to Reach $7.8 Billion
The nanoparticle analysis market presents an increasingly significant part of the overall pharmaceutical product analysis market worldwide. In the past two decades, the science of…
Acorda Therapeutics to Acquire Civitas Therapeutics
Acorda Therapeutics, Inc. recently announced it entered into an agreement to acquire Civitas Therapeutics, a privately held biopharmaceutical company, for $525 million in cash. Acorda…
Cingulate Therapeutics & Catalent Sign Exclusive ADHD Agreement
Catalent Pharma Solutions recently announced it had reached an exclusive development and licensing agreement with privately held biopharmaceutical company, Cingulate Therapeutics (CTx), to support the…
Access Pharmaceuticals Announces Global Plasma Therapeutics License
Access Pharmaceuticals has signed an exclusive global license agreement with Plasma Technologies LLC for the development and commercialization of its proprietary plasma fractionation process. Concurrently,…
Abcam & Children’s Cancer Institute Enter Exclusive Agreement
Children’s Cancer Institute and Abcam plc recently announced they have entered into an exclusive licence, supply and distribution agreement for multidrug resistance protein 4 (MRP4/ABCC4)…
SGS Announces Completion of New Lab in CA
SGS Life Science Services recently announced the completion of its fifth North American Life Science Services laboratory, in Carson, California. The new, 8,000-sq-ft GMP/GLP facility…
Daiichi Sankyo to Acquire Ambit Biosciences
Daiichi Sankyo Company, Ltd. and Ambit Biosciences jointly announced they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of…
